Company news

DexCom, Inc. news in 2023

DexCom, Inc.'s news releases, calls and decks from 2023, newest first.

View company

Dexcom to Present at 42nd Annual J.P. Morgan Healthcare Conference

December 18, 2023

Dexcom G7 is Now the Most Accurate, Smallest, Easy-to-Use CGM Connected to the Tandem t: slim X2 Insulin Pump

December 5, 2023

Dexcom Unveils Portrait Gallery to Portray Emotional Highs and Lows of Living With Diabetes on World Diabetes Day

November 13, 2023

Dexcom Reports Third Quarter 2023 Financial Results, Raises 2023 Revenue and Margin Guidance, and Announces $500 Million Share Repurchase Program

October 25, 2023

Next-Generation Dexcom G7 Continuous Glucose Monitoring System Now Available in Canada

October 4, 2023

Dexcom Solidifies Global Leadership in Continuous Glucose Monitoring With New Clinical Data Presented at EASD

October 1, 2023

Dexcom Schedules Third Quarter 2023 Earnings Release and Conference Call for October 26, 2023 at 4: 30 p.m. Eastern Time.

September 28, 2023

Dexcom Canada and RxFood Corporation Partner on Industry-Leading, AI-powered Nutrition and Glucose Monitoring Solution for Diabetes Management and Personalized Therapeutic Nutrition

September 20, 2023

Dexcom U Kicks off 2023 Season With Expanded Roster of Athletes With Diabetes, Building on First-of-its-Kind NIL Program

September 18, 2023

Dexcom Unlocks Access to Real-Time CGM for a Further Half a Million People With Diabetes in France

September 11, 2023

Dexcom G6 Strengthens Its Position as World’s Most Connected CGM System With a New Aid Offering in Germany

August 31, 2023

Dexcom Appoints Rimma Driscoll to Board of Directors

August 27, 2023

Dexcom Canada Achieves Great Place to Work® Certification for Second Consecutive Year

August 14, 2023

Dexcom Reports Second Quarter 2023 Financial Results

July 26, 2023

Dexcom Schedules Second Quarter 2023 Earnings Release and Conference Call for July 27, 2023 at 4: 30 p.m. Eastern Time

July 5, 2023

Dexcom G7 Receives Health Canada Approval: Next-Generation Continuous Glucose Monitoring System With Unmatched Accuracy Coming to Canadians

July 3, 2023

Global Continuous Glucose Monitoring Pioneer Dexcom Reveals New Plans to Bring Sensing Technology to Millions More

June 22, 2023

Dexcom Updates Long-Range Financial Targets

June 22, 2023

Dexcom G6 Strengthens Its Position as World’s Most Connected CGM System

June 20, 2023

Dexcom to Host Investor Day on June 23, 2023

June 7, 2023

Dexcom Showcases Accuracy, Reliability and Ease of Use of Its Dexcom G6 CGM System at the 66th Annual Meeting of the Japan Diabetes Society

May 9, 2023

Dexcom rtCGM is Likely to be Cost-Saving, Study Suggests

May 2, 2023

Dexcom Prices Upsized Offering of $1.1 Billion of 0.375% Convertible Senior Notes Due 2028

May 2, 2023

Dexcom Announces Proposed Offering of $1.0 Billion of Convertible Senior Notes

May 1, 2023

Dexcom Reports First Quarter 2023 Financial Results

April 26, 2023

Dexcom G6 Real-Time CGM System Now Accessible to Any Eligible Client Managing Diabetes With Insulin Through NIHB

April 26, 2023

Dexcom Commends Decision to Expand CGM Medicare Coverage to Include People With Diabetes Using All Types of Insulin

April 16, 2023

Dexcom Schedules First Quarter 2023 Earnings Release and Conference Call for April 27, 2023 at 4: 30 p.m. Eastern Time

April 5, 2023

DexCom Comments on SVB Relationship

March 12, 2023

Dexcom Showcases Accuracy, Simplicity and Connectivity of Its CGM Portfolio at ATTD Conference as Access to CGM Expands Globally

February 21, 2023

Dexcom G7 Continuous Glucose Monitoring System Will Be Available to Medicare Beneficiaries at Launch

February 12, 2023

Dexcom Reports Fourth Quarter and Fiscal Year 2022 Financial Results

February 8, 2023

Dexcom and Nick Jonas Make Super Bowl Magic to Launch New Dexcom G7 Continuous Glucose Monitoring System

February 6, 2023

Dexcom Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call for February 9, 2023 at 4: 30 p.m. Eastern Time

January 23, 2023

Dexcom G6 Real-Time CGM System Now Available to All Clients With Type 1 Diabetes Covered Under the Non-Insured Health Benefits Program

January 16, 2023

Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2022 and Initial 2023 Outlook

January 8, 2023

Dexcom Appoints Teri Lawver as Chief Commercial Officer

January 8, 2023

Dexcom to Present at 41st Annual J.P. Morgan Healthcare Conference

January 2, 2023

Calls in 2023

Decks in 2023